Published in Gastroenterology Week, April 21st, 2008
"To compare the efficacy and safety of AFR with APC for CRP. Records of 22 patients (male to female ratio, 193; mean age, 74 years) who received either APC or AFR for chronic hernatochezia caused by CRF, and who were evaluated and treated between May 1998 and April 2002, were reviewed. Complete evaluations were made three months after...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.